Stocks
Beta Bionics, Inc.BBNX
NASDAQHealthcareMedical Devices$19.16
Price as of · delayed, not real-time
A commercial-stage medical technology company focused on developing advanced insulin delivery systems for individuals with diabetes. Its lead product, an automated insulin delivery platform, has gained market traction since receiving regulatory clearance. Investors track the company for its position in the connected diabetes care market and its revenue growth trajectory.
52W Range: $8.80-$32.71
Congressional Interest in Beta Bionics, Inc. (BBNX)
No congressional trades have been disclosed for Beta Bionics, Inc. (BBNX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading BBNX?
No congressional trades found for this stock.